Background Many countries have introduced legislations for public smoking bans to reduce the harmful effects of exposure to tobacco smoke. Smoking bans cause significant reductions in admissions for acute coronary syndromes but their impact on respiratory diseases is unclear. In Geneva, Switzerland, two popular votes led to a stepwise implementation of a state smoking ban in public places, with a temporary suspension. This study evaluated the effect of this smoking ban on hospitalisations for acute respiratory and cardiovascular diseases. Methods This before and after intervention study was conducted at the University Hospitals of Geneva, Switzerland, across 4 periods with different smoking legislations. It included 5,345 patients with a first hospitalisation for acute coronary syndrome, ischemic stroke, acute exacerbation of chronic obstructive pulmonary disease, pneumonia and acute asthma. The main outcomes were the incidence rate ratios (IRR) of admissions for each diagnosis after the final ban compared to the pre-ban period and adjusted for age, gender, season, influenza epidemic and secular trend. Results Hospitalisations for acute exacerbation of chronic obstructive pulmonary disease significantly decreased over the 4 periods and were lowest after the final ban (IRR = 0.54 [95%CI: 0.42–0.68]). We observed a trend in reduced admissions for acute coronary syndromes (IRR = 0.90 [95%CI: 0.80–1.00]). Admissions for ischemic stroke, asthma and pneumonia did not significantly change. Conclusions A legislative smoking ban was followed by a strong decrease in hospitalisations for acute exacerbation of chronic obstructive pulmonary disease and a trend for reduced admissions for acute coronary syndrome. Smoking bans are likely to be very beneficial for patients with chronic obstructive pulmonary disease.
References
[1]
US Department of Health and Human Services (2006) The Health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General. Atlanta GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. http://www.cdc.gov/tobacco/data_statisti？cs/sgr/2006/. Accessed 4 September 2013.
[2]
Barnoya J, Glantz SA (2005) Cardiovascular effects of second-hand smoke: Nearly as large as smoking. Circulation 111: 2684–2698. doi: 10.1161/circulationaha.104.492215
[3]
He J, Vupputuri S, Allen K, Prerost MS, Hughes J, et al. (1999) Passive smoking and the risk of coronary heart disease. A meta-analysis of epidemiologic studies. N Engl J Med 340: 920–926. doi: 10.1056/nejm199903253401204
[4]
Oono IP, Mackay DF, Pell JP (2011) Meta-analysis of the association between secondhand smoke exposure and stroke. J Pub Health 33: 496–502. doi: 10.1093/pubmed/fdr025
[5]
Glymour MM, DeFries TB, Kawachi I, Avendano M (2008) Spousal smoking and incidence of first stroke: The Health and Retirement Study. Am J Prev Med 35: 245–248. doi: 10.1016/j.amepre.2008.05.024
[6]
He Y, Lam TH, Jiang B, Wang J, Sai X, et al. (2008) Passive smoking and risk of peripheral artery disease and ischemic stroke in Chinese women who never smoked. Circulation 118: 1535–1540. doi: 10.1161/circulationaha.108.784801
[7]
Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, et al. (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58: 100–105. doi: 10.1097/00008483-200305000-00014
[8]
Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP (2010) Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 363: 1139–1145. doi: 10.1056/nejmoa1002861
[9]
Loeb M, Neupane B, Walter SD, Hanning R, Carusone SC, et al. (2009) Environmental risk factors for community-acquired pneumonia hospitalization in older adults. J Am Geriatr Soc 57: 1036–1040. doi: 10.1111/j.1532-5415.2009.02259.x
[10]
Tan CE, Glantz SA (2012) Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: A meta-analysis. Circulation 126: 2177–2183. doi: 10.1161/circulationaha.112.121301
[11]
Callinan JE, Clarke A, Doherty K, Kelleher C (2010) Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev Issue 4. Art. No: CD005992, doi:10.1002/14651858.CD005992.pub2.
[12]
Sims M, Maxwell R, Bauld L, Gilmore A (2010) Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 340: c2161 doi:10.1136/bmj.c2161.
[13]
Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, et al. (2011) Incidence of acute myocardial infarction after implementation of a public smoking ban in Gr？ubünden, Switzerland: Two-year follow-up. Swiss Med Wkly 141: w13206 doi:10.4414/smw.2011.13206.
[14]
Naiman A, Glazier RH, Moineddin R (2010) Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ 182: 761–767. doi: 10.1503/cmaj.091130
[15]
Herman PM, Walsh ME (2011) Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health 101: 491–496. doi: 10.2105/ajph.2009.179572
[16]
Kent BD, Sulaiman I, Nicholson TT, Lane SJ, Moloney ED (2012) Acute pulmonary admissions following implementation of a national workplace smoking ban. Chest 142: 673–679. doi: 10.1378/chest.11-2757
[17]
Goodman P, Agnew M, McCaffrey M, Paul G, Clancy L (2007) Effects of the Irish smoking ban on respiratory health of bar workers and air quality in Dublin pubs. Am J Respir Crit Care Med 175: 840–845. doi: 10.1164/rccm.200608-1085oc
[18]
Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZH, et al. (2006) Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 296: 1742–1748. doi: 10.1001/jama.296.14.1742
[19]
Durham AD, Bergier S, Morisod X, Locatelli I, Zellweger JP, et al. (2011) Improved health of hospitality workers after a Swiss cantonal smoking ban. Swiss Med Wkly 141: w13317 doi:10.4414/smw.2011.13317.
[20]
Rayens MK, Burkhart PV, Zhang M, Lee S, Moser DK, et al. (2008) Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 22: 537–541. doi: 10.1016/j.jaci.2008.06.029
[21]
Etat de Genève. [Law on smoking ban in public places] (2011). Genève: Etat de Genève. French. http://www.ge.ch/legislation/rsg/f/s/rsg？_k1_18.html. Accessed 4 September 2013.
[22]
World Health Organization (1992) International statistical classification of diseases and health-related problems, Tenth Revision. Geneva, Switzerland, WHO.
[23]
Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, et al. (2009) Definition and evaluation of transient ischemic attack: A scientific statement for health care professionals. Stroke 40: 2276–2293. doi: 10.1161/strokeaha.108.192218
[24]
Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in United States. JAMA 292: 1333–1340. doi: 10.1001/jama.292.11.1333
[25]
National Centre of Influenza, Central Laboratory of Virology, University Hospitals of Geneva [Internet] (2007) Influenza surveillance in Switzerland. Sentinella Study. Winter season 2006-2007. Geneva: University Hospitals of Geneva. http://virologie.hug-ge.ch/_library/pdf/？Flu2007.pdf. Accessed 4 September 2013.
[26]
National Influenza Reference Centre, Laboratory of Virology, University Hospitals of Geneva [Internet] (2008) Influenza surveillance in Switzerland. Sentinel Report Network. Season 2007-2008. Geneva: University Hospitals of Geneva. http://virologie.hug-ge.ch/_library/pdf/？Flu2008.pdf. Accessed 4 September 2013.
[27]
National Influenza Reference Centre, Laboratory of Virology, University Hospitals of Geneva [Internet] (2009) Influenza surveillance in Switzerland. Sentinel Report Network. Season 2008–2009. Geneva: University Hospitals of Geneva. http://virologie.hug-ge.ch/_library/pdf/？Flu200809.pdf. Accessed 4 September 2013.
[28]
National Influenza Reference Centre, Laboratory of Virology, University Hospitals of Geneva [Internet] (2010) Seasonal and Influenza A (H1N1) 2009 virus surveillance in Switzerland. Season 2009–2010. Geneva: University Hospitals of Geneva. http://virologie.hug-ge.ch/_library/pdf/？Flu200910.pdf. Accessed 4 September 2013.
[29]
Etat de Genève. [Cantonal statistics: Resident population] (2011) Genève: Etat de Genève. French. http://www.ge.ch/statistique/population_？residante/welcome.asp#8. Accessed 4 September 2013.
[30]
Sapey E, Stockley RA (2006) COPD exacerbations. 2: Aetiology. Thorax 61: 250–258. doi: 10.1136/thx.2005.041822
[31]
Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, et al. (2009) The impact of SHS exposure on health status and exacerbations among patients with COPD. Int J Chron Obstruct Pulmon Dis 4: 169–176.
[32]
Swiss Federal Statistical Office (2010) Hospital statistics between year 2000 and year 2008 http://www.bfs.admin.ch/bfs/portal/fr/in？dex/themen/14/03/01/data/01.html. Accessed 27 December 2013.
[33]
Lücker LM, Kherad O, Iten A, Wagner N, Descombes M, et al. (2011) Clinical features and outcomes of hospitalized adults and children with the 2009 influenza A H1N1 infection at Geneva's University Hospital. Swiss Med Wkly 141: w13177. doi: 10.4414/smw.2011.13177
[34]
Schanzer DL, McGeer A, Morris K (2012) Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada. Influenza Other Respi Viruses doi: 10.1111/irv.12011.
[35]
Li Y, Du T, Lewin MR, Wang H, Ji X, et al. (2011) The seasonality of acute coronary syndrome and its relation with climatic parameters. Am J Emerg Med 29: 768–774. doi: 10.1016/j.ajem.2010.02.027
